Muhamad Zulfaqar Bacho

Dr. Muhamad Zulfaqar Bacho

Nanopharmaceutical Sciences, Nagoya Institute of Technology, Nagoya, Aichi, Japan
orcid
Try your best

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2025 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
MHMasashi Hattori
Masashi Hattori
DSDebarshi Saha
Debarshi Saha
Muhamad Zulfaqar BachoMuhamad Zulfaqar Bacho
Muhamad Zulfaqar Bacho
Norio ShibataNorio Shibata
Norio Shibata

31 December 2023 in Advanced Science
Verified
Journal Article
Open access
SNSrikanth Reddy Narra
Srikanth Reddy Narra
Muhamad Zulfaqar BachoMuhamad Zulfaqar Bacho
Muhamad Zulfaqar Bacho
MHMasashi Hattori
Masashi Hattori
Norio ShibataNorio Shibata
Norio Shibata
Despite the attractive properties of tetrafluorosulfanyl (SF4) compounds in drug discovery, medicinal research on SF4 molecules is hindered by the scarcity of suitable synthetic methodologies. Drawing inspiration from the well‐established Sonogashira cross‐coupling of terminal alkynes under Pd‐catalysis, it is envisioned that SF4‐alkynes can serve as effective coupling partners. To overcome the challenges associated with the electron‐deficient nature of SF4‐alkynes and the lability of the SF4 unit under transition‐metal catalysis, an aryl radical mediated Csp–Csp3 cross‐coupling reaction is successfully developed under Cu catalysis. This methodology facilitates the coupling of SF4‐alkynes with alkyl iodides, leading to the immediate synthesis of SF4‐attached drug‐like molecules. These findings highlight the potential impact of SF4‐containing molecules in the drug industry, paving the way for further research in this emerging field.

23 August 2024 in Organic Letters
Verified
Journal Article
Closed access
SNSrikanth Reddy Narra
Srikanth Reddy Narra
PAPutri Nur Arina Mohd Ariff
Putri Nur Arina Mohd Ariff
DSDebarshi Saha
Debarshi Saha
Muhamad Zulfaqar BachoMuhamad Zulfaqar Bacho
Muhamad Zulfaqar Bacho
Norio ShibataNorio Shibata
Norio Shibata

12 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
ASAzmi Johari Saiful
Azmi Johari Saiful
MMMastura Mohtar
Mastura Mohtar
MMMohd Fazli Mohammat
Mohd Fazli Mohammat
FRFatin Nur Ain Abdul Rashid
Fatin Nur Ain Abdul Rashid
Muhamad Zulfaqar BachoMuhamad Zulfaqar Bacho
Muhamad Zulfaqar Bacho
SMSharifah Aminah Syed Mohammad
Sharifah Aminah Syed Mohammad
Methicillin-resistant Staphylococcus aureus (MRSA) continues to be one of the main causes of hospital-acquired infections in all regions of the world, while linezolid is one of the only commercially available oral antibiotics available against this dangerous gram-positive pathogen. In this study, the antibacterial activity from 32 analogues of synthetic gamma-lactam heterocycles against MRSA was determined. Amongst screened analogues for the minimum inhibitory concentration (MIC) assay, compound MFM514 displayed good inhibitory activity with MIC values of 7.8–15.6 µg/mL against 30 MRSA and 12 methicillin-sensitive S. aureus (MSSA) clinical isolates, while cytotoxicity evaluations displayed a mean inhibitory concentration (IC50) value of > 625 µg/mL, displaying a potential to becoming as a lead compound. In subsequent animal studies for MFM514, a single-dose oral acute toxicity test revealed an estimated mean lethal dose (LD50) value of <5000 mg/kg, while in the mice infection test, a mean effective dose (ED50) value of 29.39 mg/kg was obtained via oral administration. These results suggest that gamma-lactam carbon skeleton, particularly MFM514, is highly recommended to be evaluated further as a new safe and efficacious orally delivered antibacterial agent against MRSA.

3 May 2023 in Asian Journal of Organic Chemistry
Verified
Journal Article
Closed access
AYArvind K. Yadav
Arvind K. Yadav
SNSrikanth Reddy Narra
Srikanth Reddy Narra
Muhamad Zulfaqar BachoMuhamad Zulfaqar Bacho
Muhamad Zulfaqar Bacho
YSYuji Sumii
Yuji Sumii
Norio ShibataNorio Shibata
Norio Shibata

19 November 2025 in Chemical Science
Verified
Journal Article
Open access
PDF file
CNChavakula Nagababu
Chavakula Nagababu
TMTakuya Muramatsu
Takuya Muramatsu
Muhamad Zulfaqar BachoMuhamad Zulfaqar Bacho
Muhamad Zulfaqar Bacho
SWShiwei Wu
Shiwei Wu
SOSeishu Ochiai
Seishu Ochiai
Norio ShibataNorio Shibata
Norio Shibata
SF 5 - and SF 4 -functionalized azepines were efficiently accessed via a PFAS-free benzene–azepine skeletal editing platform.